Welcome to our dedicated page for Privia Health Group news (Ticker: PRVA), a resource for investors and traders seeking the latest updates and insights on Privia Health Group stock.
Privia Health Group, Inc. (Nasdaq: PRVA) is a technology-driven physician enablement company that regularly issues detailed updates on its operations, value-based care performance, and network expansion. Its news flow often includes quarterly financial results, guidance updates, and announcements related to Accountable Care Organizations (ACOs) and partnerships with independent physician groups.
Investors following PRVA news can expect recurring earnings releases that highlight metrics such as total revenue, gross profit, operating income, net income, Adjusted EBITDA, Implemented Providers, Value-Based Care Attributed Lives, Practice Collections, Care Margin, and Platform Contribution. The company frequently discusses its performance in the Medicare Shared Savings Program (MSSP) and other value-based arrangements, including aggregate shared savings achieved by its Privia Quality Network ACOs.
Privia Health also uses news releases to announce strategic transactions and geographic expansion. Recent examples include a definitive agreement to acquire an ACO business from Evolent Health, Inc., which serves more than 120,000 attributed lives, and entry into the Arizona market through a partnership with Integrated Medical Services, Inc., a large independent multi-specialty practice. These updates provide insight into how the company is growing its presence across 15 states and the District of Columbia and increasing the number of attributed lives in value-based care arrangements.
In addition, PRVA news may cover governance and board changes, such as the appointment of new directors with technology and cybersecurity expertise. For readers interested in physician enablement, value-based care, and healthcare technology, the Privia Health news feed offers a view into how the company reports its progress, adjusts its full-year guidance, and describes the performance of its physician networks and ACOs over time.
Privia Health Group (Nasdaq: PRVA) reported strong Q2 2024 financial results, with notable growth across key metrics. Total revenue increased 2.2% to $422.3 million, while gross profit rose 8.9% to $98.3 million. The company saw a 16.4% increase in implemented providers to 4,504 and a 10.7% growth in value-based care attributed lives to 1.2 million. Adjusted EBITDA grew 14% to $22 million, and non-GAAP adjusted net income increased 13% to $23.5 million.
Based on strong performance, Privia Health raised its full-year 2024 guidance to the mid to high end for all metrics. The company maintains a robust financial position with $387.4 million in cash and no debt. These results demonstrate Privia Health's continued execution and growth in the healthcare sector.
Privia Health Group (Nasdaq: PRVA) will release its financial results for Q2 and the six-month period ending June 30, 2024, on August 8, 2024, before market open. The press release will be available on the company's Investor Relations website, expected by 7:00 am ET. Management will host a conference call at 8:00 am ET the same day to discuss the results and future outlook. The call will be accessible via live webcast and archived for replay on the Investor Relations site. Dial 800-715-9871 (646-307-1963 for international) with Conference ID 2580381 to join the live call.
Privia Health Group announced that Privia Medical Group received the 2024 MAP Award for High Performance in Revenue Cycle from the Healthcare Financial Management Association (HFMA). This marks the eighth recognition in nine years for the group, highlighting its robust revenue cycle capabilities and adherence to industry standards. The award was presented on June 24 at the HFMA Annual Conference in Las Vegas. Privia's success is attributed to its implementation of HFMA's Healthcare Dollars & Sense® initiatives, which focus on patient-centered best practices and benchmarks. The achievement underscores the dedication of Privia's physicians and staff to operational excellence and patient satisfaction.
On May 30, 2024, Privia Health Group (Nasdaq: PRVA) announced its participation in the 44th Annual William Blair Growth Stock Conference.
The presentation by the management team is scheduled for June 5, 2024, at 11:00 am ET / 10:00 am CT.
The live webcast and replay will be accessible on Privia Health's investor relations website.
Privia Health Group, Inc. (Nasdaq: PRVA) reported a 7.5% increase in total revenue, with gross profit up by 12.5% and non-GAAP adjusted net income rising by 16.6% in the first quarter of 2024. The company also saw an increase of 17.3% in implemented providers and reiterated its full-year 2024 guidance.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.